Clinical and Diagnostic Laboratory Immunology, May 1999, p. 444-444, Vol. 6, No. 3
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
LETTERS TO THE EDITOR
Streptococcus pneumoniae Flow-Cytometric
Phagocytosis Assay
 |
LETTER |
In a recent article, Jansen and coworkers described the use of
highly encapsulated Streptococcus pneumoniae strains in a
flow-cytometric assay for the assessment of the phagocytic capacity of
serotype-specific antibodies (1). This assay is an
elegant and easy-to-perform flow-cytometric method, which allows
the measuring of the phagocytic capacity of large numbers of
pneumococcal vaccine antisera. The results look promising, as the
interassay variation is low and the correlation with postvaccination
immunoglobulin G concentrations is good.
In order to strengthen the potential of this method to
exclusively identify anticapsular antibodies in vaccinated
individuals, the authors have used hyperimmune rabbit antisera
raised in our laboratory against a hydrophobic protein fraction of
S. pneumoniae. These antisera did not recognize protein
epitopes at the surface of heat-inactivated pneumococci that were grown
to log phase on three consecutive days.
We regret that our antisera are poorly described in the article.
This might lead to confusion. As a matter of clarification, we have
raised hyperimmune rabbit sera against a fraction of surface-associated hydrophobic proteins that were extracted from different pneumococcal strains. Indirect immunocytometric analysis has confirmed that the sera
recognize components exposed by encapsulated pneumococci. In addition,
the in vitro phagocytic capacity of the sera was high with
non-heat-inactivated pneumococci that were grown to log phase.
Importantly, both antigenic surface exposure and phagocytic capacity of
the sera were independent of the capsular type and the genotype of the
pneumococcus (2).
The experiments described by Jansen and coworkers using the hyperimmune
sera raised against the fraction of surface-associated hydrophobic
pneumococcal proteins have been carried out independently in our
laboratory. Heat inactivation was omitted for obvious reasons. In
the experiments using non-heat-inactivated pneumococci that were
grown to stationaryphase or to log phase on three consecutive days, the
hyperimmune sera demonstrated phagocytic capacity (Fig. 1). Based on these observations, we conclude that the
flow-cytometric phagocytosis assay described by Jansen and coworkers is
also suitable for measuring antibodies that recognize protein epitopes
exposed at the surface of encapsulated pneumococci.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
The opsonic activity of preimmune (open symbols) and
hyperimmune (closed symbols) rabbit sera raised against the
surface-associated protein fraction of S. pneumoniae by
using a pneumococcal clinical isolate grown to stationary phase
(triangles) or to log phase (circles) on three consecutive days. In
these experiments non-heat-inactivated bacteria were used.
|
|
 |
FOOTNOTES |
*
Phone: 31-10-408-8224
Fax: 31-10-408-9486
E-mail: hermans{at}kgk.fgg.eur.nl
 |
REFERENCES |
| 1.
|
Jansen, W. T. M.,
J. Gootjes,
M. Zelle,
D. V. Madore,
J. Verhoef,
H. Snippe, and A. F. M. Verheul.
1998.
Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.
Clin. Diagn. Lab. Immunol.
5:703-710[Abstract/Free Full Text].
|
| 2.
| Overweg, K., R. de Groot, A. F. M. Verheul, A. Kerr, T. J. Mitchell, and P. W. M. Hermans. Opsonic antibodies
directed against hydrophobic surface proteins of Streptococcus
pneumoniae confer passive protection in mice. Unpublished data.
|
| | | | |
Karin Overweg
Ronald de Groot
Peter W. M. Hermans*
Department of Pediatrics Erasmus University Medical Center Rotterdam P.O. Box 1738 3000 DR Rotterdam The Netherlands
|
 |
AUTHOR'S REPLY |
The purpose of the described phagocytosis assay is to measure the
phagocytic capacity of serotype-specific antibodies. Using highly
encapsulated, heat-inactivated pneumococci, only anticapsular polysaccharide antibodies were able to promote phagocytosis. As we
stated in Discussion, a potential disadvantage of the use of heat
treatment is the potential denaturation of protein epitopes on the
pneumococcus. Therefore, when the purpose is to evaluate the opsonic
capacity of antipneumococcal protein antibodies, live and
heat-inactivated strains should initially be compared.
We never intended to suggest that the described protein antisera of
Overweg and coworkers were not able to promote phagocytosis of
non-heat-inactivated strains. We agree that their protein antisera do
promote phagocytosis of non-heat-inactivated bacteria and thereby may have protective capacities.
| | | | |
W. T. M. Jansen
H. Snippe
A. F. M Verheul
Eijkman-Winkler Institute for Microbiology, Infectious Diseases
and Inflammation Utrecht University Hospital 3584 CX Utrecht The Netherlands
|
Clinical and Diagnostic Laboratory Immunology, May 1999, p. 444-444, Vol. 6, No. 3
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.